A novel therapeutic approach for LPIN1 mutation–associated rhabdomyolysis—The Austrian experience

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-4598|52|3|437-439

ISSN： 0148-639x

Source： MUSCLE AND NERVE, Vol.52, Iss.3, 2015-09, pp. : 437-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Favorable four‐yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation‐associated HUS

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 6, 2015-09 ,pp. : E130-E134

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia

By  

Molecular Neuropsychiatry, Vol. 1, Iss. 3, 2015-0 ,pp. : 125-144

Karger

Access to resources Recommend Favorite

Systemic GLIPR1‐ΔTM protein as a novel therapeutic approach for prostate cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 134, Iss. 8, 2014-04 ,pp. : 2003-2013

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rhabdomyolysis and fluctuating asymptomatic hyperCKemia associated with CACNA1S variant

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 2, 2018-02 ,pp. : 417-419

John Wiley & Sons Inc

Access to resources Recommend Favorite

A novel TGM1 mutation, leading to multiple splicing rearrangements, is associated with autosomal recessive congenital ichthyosis

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 307-6938, Iss. 7, 2015-10 ,pp. : 757-760

John Wiley & Sons Inc

Access to resources Recommend Favorite